Electronic Health Record-Enabled Evidence-Based Smoking Cessation Quality Improvement Implementation Program

Smoking Cessation Clinical Trial

Official title:

Electronic Health Record-Enabled Evidence-based Smoking Cessation Quality Improvement Program

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT04107857
• Other study ID #: 89276
• Secondary ID: P30CA091842
• Status: Active, not recruiting
• Start date: October 2, 2019
• Est. completion date: October 2, 2024

Study information

• Verified date: November 2023
• Source: Washington University School of Medicine
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The goal of this quality improvement program is to implement, evaluate, and sustain an evidence-based smoking cessation treatment program with a population-based approach so that all patients at the Siteman Cancer Center, Washington University, Barnes-Jewish Hospital, BJC Healthcare, and satellite locations receive assessment of smoking and all smokers receive treatment support.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 1000000
• Est. completion date: October 2, 2024
• Est. primary completion date: April 2, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

-Patients seen at Siteman Cancer Center, Washington University, Barnes-Jewish Hospital, BJC Healthcare, or any of the satellite locations

Exclusion Criteria:

-None

Related Conditions & MeSH terms

• Smoking Cessation

Intervention

Behavioral:
• ELEVATE enhancement to electronic health record (EHR) to improve cessation counseling offer
Brief advise to quit smoking Referral to Missouri/Illinois Quitlines, Smokefree.TXT, or smokefree.gov
• ELEVATE enhancement to electronic health record (EHR) to improve smoking cessation medication offer
-Nicotine replacement therapy, varenicline, bupropion, or combination therapy (not provided by study)
• Data Driven Feedback reports
-Feedback reports will be based on data

Locations

Country	Name	City	State
United States	Washington University School of Medicine	Saint Louis	Missouri

Sponsors (3)

Lead Sponsor	Collaborator
Washington University School of Medicine	National Cancer Institute (NCI), National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Clinic level percentage of patients receiving brief counseling		From 6 months pre-intervention through 6 months post-intervention
Primary	Clinic level percentage of smokers offered referral to additional counseling		From 6 months pre-intervention through 6 months post-intervention
Primary	Clinic level percentage of smokers offered medication		From 6 months pre-intervention through 6 months post-intervention
Secondary	Clinic level percentage of patients receiving brief counseling		Estimated to be 12 months pre-intervention and 12, 24, 36, and 48 months post-intervention
Secondary	Clinic level percentage of smokers offered referral to additional counseling		Estimated to be 12 months pre-intervention and 12, 24, 36, and 48 months post-intervention
Secondary	Clinic level percentage of smokers offered medication		Estimated to be 12 months pre-intervention and 12, 24, 36, and 48 months post-intervention
Secondary	Clinic level percentage of smokers receiving smoking assessment		Estimated to be 12 months pre-intervention and 12, 24, 36, and 48 months post-intervention
Secondary	Clinic level percentage of smokers receiving cessation medication		Estimated to be 12 months pre-intervention and 12, 24, 36, and 48 months post-intervention
Secondary	Number of patients who have abstained from smoking		Estimated to be 6 months post-intervention

External Links

•   Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
•   Related Info